ALT5 SIGMA CORP (ALTS) Stock Fundamental Analysis

NASDAQ:ALTS • US47089W1045

1.39 USD
-0.03 (-2.11%)
At close: Feb 27, 2026
1.415 USD
+0.03 (+1.8%)
After Hours: 2/27/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

ALTS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 238 industry peers in the Capital Markets industry. ALTS has a bad profitability rating. Also its financial health evaluation is rather negative. ALTS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year ALTS has reported negative net income.
  • In the past year ALTS has reported a negative cash flow from operations.
  • ALTS had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ALTS reported negative operating cash flow in multiple years.
ALTS Yearly Net Income VS EBIT VS OCF VS FCFALTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.02%, ALTS is in line with its industry, outperforming 42.92% of the companies in the same industry.
  • The Return On Equity of ALTS (2.13%) is worse than 68.75% of its industry peers.
Industry RankSector Rank
ROA 2.02%
ROE 2.13%
ROIC N/A
ROA(3y)-8.77%
ROA(5y)-34.52%
ROE(3y)-9.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTS Yearly ROA, ROE, ROICALTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

  • ALTS has a better Profit Margin (133.06%) than 98.75% of its industry peers.
  • ALTS has a Gross Margin (43.49%) which is comparable to the rest of the industry.
  • ALTS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 133.06%
GM 43.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.18%
GM growth 5Y17.71%
ALTS Yearly Profit, Operating, Gross MarginsALTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, ALTS has more shares outstanding
  • Compared to 5 years ago, ALTS has more shares outstanding
  • ALTS has a worse debt/assets ratio than last year.
ALTS Yearly Shares OutstandingALTS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ALTS Yearly Total Debt VS Total AssetsALTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • ALTS has an Altman-Z score of 1.21. This is a bad value and indicates that ALTS is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.21, ALTS is doing good in the industry, outperforming 62.08% of the companies in the same industry.
  • ALTS has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.01, ALTS belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 1.21
ROIC/WACCN/A
WACCN/A
ALTS Yearly LT Debt VS Equity VS FCFALTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 0.79 indicates that ALTS may have some problems paying its short term obligations.
  • The Current ratio of ALTS (0.79) is worse than 62.08% of its industry peers.
  • A Quick Ratio of 0.79 indicates that ALTS may have some problems paying its short term obligations.
  • The Quick ratio of ALTS (0.79) is worse than 61.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.79
ALTS Yearly Current Assets VS Current LiabilitesALTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 83.08% over the past year.
  • ALTS shows a strong growth in Revenue. In the last year, the Revenue has grown by 250.06%.
  • ALTS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -18.62% yearly.
EPS 1Y (TTM)83.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%530.84%
Revenue 1Y (TTM)250.06%
Revenue growth 3Y-32.08%
Revenue growth 5Y-18.62%
Sales Q2Q%53.31%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.61% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ALTS will show a very strong growth in Revenue. The Revenue will grow by 65.13% on average per year.
EPS Next Y-87.54%
EPS Next 2Y-4.52%
EPS Next 3Y28.61%
EPS Next 5YN/A
Revenue Next Year205.43%
Revenue Next 2Y125.77%
Revenue Next 3Y84.48%
Revenue Next 5Y65.13%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALTS Yearly Revenue VS EstimatesALTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
ALTS Yearly EPS VS EstimatesALTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • ALTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALTS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALTS Price Earnings VS Forward Price EarningsALTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALTS Per share dataALTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALTS's earnings are expected to grow with 28.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.52%
EPS Next 3Y28.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ALTS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALT5 SIGMA CORP

NASDAQ:ALTS (2/27/2026, 8:00:00 PM)

After market: 1.415 +0.03 (+1.8%)

1.39

-0.03 (-2.11%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-18
Earnings (Next)03-27
Inst Owners45.72%
Inst Owner Change0%
Ins Owners0.69%
Ins Owner Change0%
Market Cap175.61M
Revenue(TTM)24.89M
Net Income(TTM)33.12M
Analysts82.86
Price Target18.36 (1220.86%)
Short Float %12.09%
Short Ratio3.35
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-9.92%
Min Revenue beat(2)-25.83%
Max Revenue beat(2)5.98%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.06
P/FCF N/A
P/OCF N/A
P/B 0.11
P/tB 0.12
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.61
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.2
BVpS12.32
TBVpS11.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.02%
ROE 2.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 133.06%
GM 43.49%
FCFM N/A
ROA(3y)-8.77%
ROA(5y)-34.52%
ROE(3y)-9.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.18%
GM growth 5Y17.71%
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.79
Altman-Z 1.21
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%530.84%
EPS Next Y-87.54%
EPS Next 2Y-4.52%
EPS Next 3Y28.61%
EPS Next 5YN/A
Revenue 1Y (TTM)250.06%
Revenue growth 3Y-32.08%
Revenue growth 5Y-18.62%
Sales Q2Q%53.31%
Revenue Next Year205.43%
Revenue Next 2Y125.77%
Revenue Next 3Y84.48%
Revenue Next 5Y65.13%
EBIT growth 1Y-188.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year57.09%
EBIT Next 3Y44.5%
EBIT Next 5Y44.66%
FCF growth 1Y-2815.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1549.08%
OCF growth 3YN/A
OCF growth 5YN/A

ALT5 SIGMA CORP / ALTS FAQ

Can you provide the ChartMill fundamental rating for ALT5 SIGMA CORP?

ChartMill assigns a fundamental rating of 2 / 10 to ALTS.


Can you provide the valuation status for ALT5 SIGMA CORP?

ChartMill assigns a valuation rating of 1 / 10 to ALT5 SIGMA CORP (ALTS). This can be considered as Overvalued.


Can you provide the profitability details for ALT5 SIGMA CORP?

ALT5 SIGMA CORP (ALTS) has a profitability rating of 2 / 10.


How financially healthy is ALT5 SIGMA CORP?

The financial health rating of ALT5 SIGMA CORP (ALTS) is 2 / 10.